62152 Long-term safety and tolerability of bimekizumab in patients with axial spondyloarthritis and psoriatic arthritis: Updated results from phase 2b/3 studies and their open-label extensions.

Joseph F. Merola, Philip J. Mease, Denis Poddubnyy, Rajan Bajracharya, Alexander Marten, Myriam Manente, Luke Peterson, Katy White, Peter Nash, Lianne S. Gensler. 62152 Long-term safety and tolerability of bimekizumab in patients with axial spondyloarthritis and psoriatic arthritis: Updated results from phase 2b/3 studies and their open-label extensions. Journal of the American Academy of Dermatology. 2025 Sep 1; 93(3):ab245.